Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Pharma News, Views & Analysis
Filter
News
Articles
Podcasts
Infographics
Advertise With Us
Advertise With Us
ViiV, Roche and Gilead lead pharma patient group rankings
ViiV leads the 2024/25 pharma company reputation rankings, with the PatientView report also finding ways in which the industry can improve.
Read more
New ABPI Code of Practice includes updates from PMCPA
The 2024 edition of the ABPI’s Code of Practice was published today, including new procedures under the PMCPA.
GSK pursues co-administration of RSV and shingles vaccines
New findings have been revealed on the co-administration of GSK’s RSV and existing shingles vaccine.
Musk's vision implant gets FDA breakthrough device tag
Neuralink, Elon Musk’s brain-chip startup, has been given breakthrough device designation from the FDA for its experimental implant aimed at restoring vision.
Warner Biddle takes top job at Kyverna Therapeutics
Warner Biddle has been appointed as CEO, Kyverna Therapeutics, following the resignation of Peter Maag this week.
Roche's twice-yearly MS injection wins FDA approval
The FDA has approved Roche’s subcutaneous injection for relapsing multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS).
Company reputation key to HCP prescribing decisions
New research shows that healthcare professionals consider a company’s leadership in a specific disease area and its overall reputation to be influential in prescribing decisions.
FDA lifts partial clinical hold on Rezolute hyperinsulinism treatment
The lift is based on new research showing that the previous adverse effects in laboratory rats may not have been caused by the drug itself.
New AI-focused RNA collaboration for Eli Lilly
Eli Lilly has entered into a research collaboration with Genetic Leap, a private company focused on AI, to advance the development of RNA-based genetic medicines.
Loading posts...
« Previous
1
…
12
13
14
15
16
…
26
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View